MARKET

KMDA

KMDA

Kamada Ltd
NASDAQ
6.94
+0.08
+1.17%
After Hours: 6.79 -0.15 -2.16% 18:54 05/16 EDT
OPEN
6.87
PREV CLOSE
6.86
HIGH
6.99
LOW
6.84
VOLUME
37.14K
TURNOVER
--
52 WEEK HIGH
8.90
52 WEEK LOW
4.608
MARKET CAP
399.08M
P/E (TTM)
27.75
1D
5D
1M
3M
1Y
5Y
1D
Wall Street Analysts Believe Kamada (KMDA) Could Rally 106.56%: Here's is How to Trade
NASDAQ · 16h ago
Is Kamada (KMDA) Stock Undervalued Right Now?
NASDAQ · 16h ago
Kamada’s Robust Growth and Strategic Expansion Drive Buy Rating
TipRanks · 17h ago
Kamada Ltd’s Earnings Call Highlights Strong Growth and Expansion
TipRanks · 1d ago
Kamada Price Target Maintained With a $15.00/Share by Benchmark
Dow Jones · 1d ago
Benchmark Reiterates Buy on Kamada, Maintains $15 Price Target
Benzinga · 1d ago
Analysts Offer Insights on Healthcare Companies: Verve Therapeutics (VERV), Nkarta (NKTX) and Kamada (KMDA)
TipRanks · 1d ago
Compared to Estimates, Kamada (KMDA) Q1 Earnings: A Look at Key Metrics
NASDAQ · 2d ago
More
About KMDA
Kamada Ltd is Israel based company, focused on plasma-derived protein therapeutics with a commercial product portfolio and a late-stage product pipeline. The Company uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

Webull offers Kamada Ltd stock information, including NASDAQ: KMDA real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, KMDA stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading KMDA stock methods without spending real money on the virtual paper trading platform.